REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Muller Pharma S.R.O. (Czech Republic)

Main Activities: All Other Miscellaneous Food Manufacturing
Full name: Dr. Muller Pharma S.R.O. Profile Updated: October 25, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Dr. Muller Pharma S.R.O. is a company in Czech Republic, with a head office in Hradec Kralove. It operates in the All Other Miscellaneous Food Manufacturing industry. The company was established on April 13, 1995. It currently has a total number of 200 - 249 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 46.43% in 2022. Its’ total assets recorded a growth of 74.73%. In 2022, Dr. Muller Pharma S.R.O.’s net profit margin increased by 12.6%.

Headquarters
U Mostku 182
Hradec Kralove; Kralovehradecky; Postal Code: 50341

Contact Details: Purchase the Dr. Muller Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Muller Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dr. Muller Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Dr. Muller Pharma S.R.O. report to view the information.
Incorporation Date:
April 13, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Megafyt Pharma S.R.O.
100%
Pigi Tea S.R.O.
100%
Company Performance
Financial values in the chart are available after Dr. Muller Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
46.43%
Total operating revenue
47.6%
Operating profit (EBIT)
343.06%
EBITDA
111.64%
Net Profit (Loss) for the Period
365.11%
Total assets
74.73%
Total equity
44.36%
Operating Profit Margin (ROS)
15.5%
Net Profit Margin
12.6%
Return on Equity (ROE)
11.34%
Debt to Equity Ratio
26.39%
Quick Ratio
2.11%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?